Collaboration

TYK Medicines, Inc. is an innovative biotechnology company founded by MNC veterans in 2017, focusing on the discovery of new-generation Kinase Inhibitors to address the unmet medical needs in cancer therapy. TYK medicines has a diversified pipeline with 10+ compounds including multiple phases from the PCC stage to Phase III clinical trial. The company is committed to providing patients with more effective and safer anti-tumor drugs. We are delighted and open to establishing extensive cooperation with potential partners to accelerate the development and commercialization of these projects globally. We look forward to communicating with you about the potential partnership.

Contact information